CMP:166.95 TARGET PRICE:186 INVESTMENT RATIONALE Jubilant Organosys is a leading pharmaceutical service provider of end to end services from drug discovery, synthesis of complex intermediates and API’s (active pharmaceutical ingredients), to finished dosage forms. The company has two major lines of business one the Pharmaceutical & Life sciences Product and Service (PLSPS) and Industrial...